How ANNs Are Revolutionizing Medicine
Artificial Neural Networks (ANNs) have been quietly evolving since the 1950s, but their impact on healthcare has accelerated dramatically in recent years. Unlike modern Large Language Models (LLMs) like ChatGPT,…
What You Should Know:
– Castle Biosciences, a company dedicated to improving health through innovative diagnostic tests that guide patient care announced it has signed a definitive agreement to acquire Capsulomics, Inc., which does business…
Continue Reading
Josh Duncan, Chief Growth Officer at Harrison.ai
What You Should Know:
– Harrison.ai, a global healthtech company developing AI-powered diagnostic support and workflow solutions, today announced the appointment of Josh Duncan as its first Chief Growth…
Continue Reading
A cancer diagnostic tool will be rolled out across the NHS to help cut treatment delays and boost survival rates, the government has announced.
The Cancer 360 tool, which is built into the federated data…
The integration of patient-reported outcomes (PROs) in digital health (DH) trials for cardiovascular diseases (CVDs) remains unknown. We searched ClinicalTrials.gov for randomized trials that tested DH interventions in CVDs from 2004 to 2024. The…
Continue Reading
Keratinocyte carcinoma, such as Actinic Keratosis (AK) and Basal Cell Carcinoma (BCC), share similar clinical presentations but differ significantly in prognosis and treatment, highlighting the importance of effective screening. Optical coherence tomography (OCT) shows…
Continue Reading
Jim Salamon, National Leader for Medical Team, LG Electronics USA
The latest medical display technology plays a critical role in enhancing and advancing the way physicians diagnose, monitor, and treat patients, assisting both physicians and…
Continue Reading
Breakthrough AI Innovations Transform Breast Care
GE HealthCare is showcasing its cutting-edge advancements in diagnostic accuracy and patient-centered breast care at the 2025 Society of Breast Imaging Symposium in Colorado Springs, Colorado (April 24-27, 2025)….
Children’s Health Ireland (CHI) has signed a five-year contract with medical imaging and cyber security company Sectra.
A deal was signed in January 2025 following a four-month procurement, with the aim of saving healthcare teams…
Accurate assessment of progression and disease course in multiple sclerosis (MS) is vital for timely and appropriate clinical intervention. The gradual transition from relapsing-remitting MS (RRMS) to secondary progressive MS (SPMS) is often diagnosed…
Continue Reading
